The Global Biobanking Market is valued at US$ 82.65 billion in 2025 and is projected to reach US$ 197.59 billion by 2034, expanding at a CAGR of 10.17% from 2025 to 2034. The market is supported by growing demand for advanced health monitoring, personalized health technologies, data-driven wellness solutions, and innovative healthcare applications.

Biobanking Market Overview

The supplied market information describes an ecosystem involving technologies, products, and services that enable individuals to optimize physical and mental performance through scientific principles and data. These applications include wearable devices, continuous glucose monitoring, genetic testing, nutritional supplements, smart rings, sleep optimization, neurotechnology, and personalized health platforms.

The growing availability of connected health technologies is enabling consumers, athletes, healthcare practitioners, and wellness-focused users to monitor physiological parameters and make more data-driven health decisions.

For example, in May 2026, WHOOP, Inc. introduced WHOOP 5.0 and WHOOP MG, featuring cardiovascular health information, blood-pressure estimation, Healthspan capabilities, and sleep and recovery analytics. The development highlights the increasing integration of wearable sensors, continuous monitoring, and AI-based recommendations into personalized wellness solutions.

Key Factors Driving Market Growth

The market is benefiting from increasing consumer interest in continuous health monitoring and preventive wellness. Key growth factors include:

• Rising adoption of wearable health devices
• Growing demand for personalized health platforms
• Increasing use of AI-based health recommendations
• Expansion of continuous health monitoring technologies
• Growing interest in preventive healthcare and wellness
• Increasing adoption of smart rings and connected devices

North America Market Analysis

North America is identified in the supplied information as a leading region, supported by strong adoption of wearable health devices, digital health platforms, and preventive wellness technologies.

According to the provided market information, more than 45% of U.S. adults use wearable technology to monitor health and fitness. The source also notes that 6 in 10 U.S. adults have at least one chronic disease, supporting demand for continuous health monitoring and preventive wellness solutions.

In May 2026, Oura Health Ltd. launched the Oura Ring 5 in North America, introducing features including blood-pressure signals, nighttime breathing monitoring, GLP-1 health insights, AI-enabled health guidance, and enhanced sensor accuracy.

Market Segmentation

The Global Biobanking Market is segmented by:

• Specimen Type
• Biobank Type
• Storage Type
• Offering
• Application
• End User

Get the Complete Market Research Report

The Biobanking Market Report by RNP Market Research provides insights into market size, growth trends, segmentation, regional developments, competitive analysis, and emerging opportunities.

Looking for detailed market data or customized research? Contact RNP Market Research to discuss your requirements.

Source: RNP Market Research